NEW YORK, NY / ACCESSWIRE / December 13, 2018 / U.S. equities closed higher on Wednesday amidst renewed hopes over the U.S.-China trade talks. According to a report in Wall Street Journal, China is working on a plan to expand their access to foreign companies that will support the U.S.-China trade
The Market Edge Initiates Coverage on:
Applied Genetic Technologies Corporation
Novavax's stock jumped 11.21% Wednesday, to close the day at $2.48. The stock recorded a trading volume of 17,263,454 shares, which was above its three months average volume of 6,833,292 shares. In the last year, Novavax's shares have traded in a range of 1.05 - 2.75. The share price has gained 136.19% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.87 is above its 200-day moving average of $1.62. Shares of Novavax have gained roughly 45.03 percent in the past month and are up 100 percent year-to-date.
Access The Market Edge's Novavax, Inc. Research Report:
On Wednesday, shares of Applied Genetic Technologies recorded a trading volume of 347,527 shares, which was above the three months average volume of 167,030 shares. The stock ended the day 7.36% higher at $6.56. The share price has fallen 12.53% from its 52
Access The Market Edge's Applied Genetic Technologies Corporation Research Report:
The Market Edge
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: The Market Edge